Background: Our aim was to review UK practice in the management of radical retropubic prostatectomy and identify opportunities to reduce LOS to American levels. Methods: A survey was conducted of BAUS members regarding LOS and postoperative management. Results: Out of 551 surveys 126 were returned. Mean LOS in the UK is 5.2 days. Opiate analgesia, PCA and postoperative epidural may delay discharge. Diet and mobilization are commenced at 1.7 and 2.1 days, respectively. Conclusion: Care pathways can safely reduce LOS to 2 days. Protocols to reduce LOS in the UK should be assessed and their impact on cost and quality-of-life evaluated.
Introduction
In the management of localized prostate cancer, radical retropubic prostatectomy (RRP) remains the surgical treatment of choice. Attempts to improve standardof-care have focused on perioperative management and quality of life outcomes. Concerns about healthcare costs have provided the stimulus for American physicians, in particular, to cut their costs while simultaneously maintaining (or improving) standards of patient care. Length of hospital stay has been identified as the main determinant of cost 1 and as a result, critical-care pathways have been developed in the United States, geared towards earlier discharge. [1] [2] [3] [4] [5] [6] [7] During the 1990 s, various groups were able to reduce hospital stay by taking an aggressive approach to diet, fluids and mobilization and by eliminating the use of epidural anaesthesia for postoperative pain management. Koch et al 2 reduced cost by 44% and decreased the mean length of stay from 5.7 to 3.6 days.
Between 1996 and 2000, this department developed a care pathway (Figure 1 ), which has resulted in the shortest reported LOS of just 1.34 days with 74.2% of patients being discharged on the first postoperative day. 8 The key feature of this pathway is the use of Spinal and Epidural anaesthesia instead of General Anaesthetic. The epidural is removed in recovery and a single dose of IM Methadone given. Oral Paracetamol and NSAIDs are started at 4 h postoperatively and oral fluids commenced as soon as they are tolerated. Patients start to mobilize on the evening of surgery. They are then discharged on the following morning, provided they are tolerating oral diet, walking unassisted and are apyrexial.
Patient satisfaction surveys have reported good results and there is no increase in complications or readmissions. 8, 9 Same day discharge has also been evaluated. Hajjar et al 4 have conducted a pilot study in which 10 patients underwent Radical Retropubic Prostatectomy as day cases without an increase in complications.
In the United Kingdom, there has been less of an imperative to economise and hospital stays remain longer. In our pilot study in 2002, this was typically 5-8 days (mean 5.2). 10 The aim of this study was to assess current UK practice in the perioperative management of RRP and to raise questions about how Short-Stay Radical Retropubic Prostatectomy could be achieved in the United Kingdom. The survey (Appendix 1) comprised 23 questions about: the number of cases performed per annum; the average length of stay; anaesthetic use; postoperative analgesia; preoperative counselling; drain and catheter protocols; diet and fluids; mobilisation; LN dissection; blood transfusion and readmission rate.
Method

Results
Out of 551, 126 (23%) urologists returned completed surveys. Of these, 44 performed no RRPs and were excluded from further analysis. One urologist had retired and was excluded. This left a study group of 82 questionnaires.
The mean number of RRPs performed per annum was 27.0 with a range of 6-120 and s.d. of 19.4. Mean op time was 143.0 min (range 75-300, s.d. 37.7). Mean readmission rate was 3.4%. There were no statistically significant correlations between the number of cases performed per annum, the operating time and the readmission rate.
Mean length of stay in the UK was 5.24 days (range 2-12, s.d. 1.60, median 5) ( Figure 2 ). All but one surgeon made use of either epidural or PCA for postoperative pain control (for a mean of 2.14 days). The one surgeon who did not make use of these modalities had the earliest discharge (2 days).
In addition to epidural anaesthesia or PCA, 42 of 82 (51%) surgeons used paracetamol or NSAIDs for postoperative analgesia with the remaining 40 (49%) using oral or parenteral opiates as well. The use of nonopiate analgesia was associated with a shorter hospital stay (4.97 vs 5.52 days) although this did not quite reach statistical significance (P ¼ 0.09).
Patients mobilised at a mean of 2.1 days (range 0-4, median 2), commenced oral fluids at a mean of 1.1 days (range 0-2, median 1) and solid diet at a mean of 1.7 days (range 0-4, median 2) -where 0 denotes the day of surgery.
A surgical drain was used in 97% of cases and was removed at a mean of 2.16 days with 50 ml being the average volume for directing its removal.
The urethral catheter was removed at a mean of 16 days and a median of 14 days (range 7-28 days). Only 16% of surgeons make use of cystograms in directing catheter removal and there was no correlation between length of catheterisation and the use of cystograms.
Criteria for performing lymph node (LN) dissection varied widely with 36% of surgeons performing LN dissection on all patients and 7% LN sampling only if nodes were palpable intraoperatively. The PSA level above which LN dissection was performed ranged from 6 to 20 (mode ¼ 10) and the Gleason score ranged from 6 to 8 (mode ¼ 7).
All patients received verbal counselling by either a doctor or specialist nurse or both. In addition, 44/82 (54%) urologists offered written information about the procedure. Figure 1 Short-stay care pathway for RRP. Figure 2 Distribution of length of hospital stay in UK.
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Patients received blood transfusion in 33.4% of cases (range 0-96%). Only 12 surgeons (14.6%) used autologous blood transfusion.
Discussion
This study provides valuable information about current clinical practice in the United Kingdom in the postoperative management of Radical Retropubic Prostatectomy.
One outcome is that the response rate from BAUS members appears to be very low. A possible explanation for this is that, although the questionnaire was sent to individual urologists, many were returned for entire departments. In addition, it is likely that many urologists who do not perform RRP failed to respond to the questionnaire. In 1999/2000, 62% of urologists did not perform any RRPs. 11 If we presume this figure to be reasonably stable, that would suggest that there are now in the region of 340 urologists in the UK not performing RRP. Thus, their failure to respond would have little or no impact on the results.
Similarly, we estimate that there are around 210 urologists in the UK who are performing RRP. Although we received only 83 responses from this group, we believe that the majority of prostatectomies are accounted for; the total estimated number of cases per annum in this study was 2215 which compares well with Ravichandran's figure of 1465 for 1999/2000. 11 Some of this increase may be the result of surgeons overestimating their case-load. Some, however, may be a true reflection of the growing popularity of RRP as PSA screening becomes more widespread and disease is identified at an earlier stage.
In 2000, Ravichandran et al 11 reported that less than 18% of urologists undertaking Radical Prostatectomy perform more than 20 per year. In contrast, 53/82 (65%) of this study group were performing more than 20 per year and the mean number performed was 27.0. The mean is higher than expected and may be an indication that surveys are more likely to be returned by surgeons who are performing the most surgery. It may also represent pooling of departmental results.
Before early discharge becomes feasible, existing trends will need to be modified, in particular, attitudes towards anaesthesia and analgesia. General anaesthesia remains the standard of care in the UK, either alone (42.7%) or in combination with epidural (51.2%), spinal (1.2%) or caudal (1.2%) anaesthesia. The use of combined epidural and spinal anaesthetic, without GA, has been shown to be effective in this setting, however, and offers advantages over General Anaethesia in the recovery period.
3 Pain control is excellent, incidence of ileus is low and commencement of oral intake earlier. This allows early introduction of oral analgesia and removal of the epidural. By eliminating the use of epidural or PCA for postoperative pain management, patients are able to mobilise sooner thus expediting what is a rate-limiting step for discharge. The single surgeon in this study who did not use postoperative epidural or PCA had the shortest LOS.
The use of nonopiate analgesia was associated with a shorter LOS than opiate analgesia. It is unclear whether this is a primary association as a feature of a more traditional approach to postoperative management, or whether the elimination of opiates speeds recovery.
The need for cystography in assessing the integrity of the vesico-urethral anastomosis prior to catheter removal remains an area of practice in which there is much disparity. While some surgeons routinely perform cystography at 28 days before removing the catheter, others remove the catheter at day 7 without radiographic evidence of anastomotic integrity. Best-practice in this issue is yet to be elucidated.
Preoperative counselling has an important role in preparing patients for short-stay surgery. In this practice, patients undergo a 1-h counselling session with a specialist nurse as well as with the surgeon. In addition they are provided with detailed written information on the procedure and the course of their hospital stay and recovery. We believe that this is integral to the patients' acceptance of what remains an unusual approach to this scale of surgery.
Undertaking short-stay RRP in the UK would require a significant change in the traditional values upheld by both doctors and patients. It requires training and education of anaesthetic staff, theatre staff, nurses and physiotherapists. Furthermore, there are obstacles at a management level; concerns about 'losing' empty beds, additional costs of increased bed turnover, allocation of theatre time and a potentially higher demand on community medicine. The cost reduction per procedure, however, is significant and the net result could be beneficial to the British healthcare system.
As a result of the growing use of PSA screening in the United Kingdom, there is already an upward trend in the incidence of prostate cancer in the UK and conjecture that incidence may reach levels seen in the USA. The NICE Guidance on Cancer Services, estimates that the rise in incidence of prostate cancer, between 2001 and 2004, will result in additional costs ranging between d15.4 and d43.8 million. 12 Although there is a paucity of evidence definitively supporting radical treatment over active monitoring, RRP remains a mainstay of treatment and will be a significant constituent of these costs. To make use of a strategy for undertaking RRP in an economically efficient way is a logical means of containing these rising expenses.
The implications of a shorter hospital stay run further than merely reducing expenditure. Patient satisfaction, complications and readmission rates are comparable to conventional stays. It has been suggested that recovering at home prompts patients to mobilise sooner, eat better and be less dependant on analgesics. 4 In addition, there is less exposure to the risks of hospital-acquired infection. Furthermore, reducing hospital stay might prove an effective means of meeting the new targets set out in the national cancer guidelines.
Conclusion
In spite of evidence from the United States that short-stay prostatectomy is a safe and cost-effective practice, with a high level of patient satisfaction, it has not been adopted in the UK. Hospital stays remain longer, diet, fluids and mobilisation are delayed and anaesthesia and analgesia impose limitations on the rate of recovery. To implement a short-stay protocol requires the Urological team to significantly readdress traditional paradigms but by reducing stay, resources can be optimised, waiting lists reduced and a high standard of care delivered to patients. A short-stay pathway is being developed in Bristol and our experience with its implementation will be reported once it has been evaluated.
